At the completion of this activity, the participant will be able to:
1. Summarize the key changes to the 2026 ACC/AHA Dyslipidemia guideline recommendations
2. Analyze the LDL-C and non-HDL treatment goals for primary and secondary prevention of ASCVD
3. Compare the LDL-C lowering efficacy and cardiovascular outcomes data for statins and non-statin therapies
4. Apply the 2026 ACC/AHA Dyslipidemia guideline recommendations to patients with dyslipidemia in a stepwise approach to intensify lipid-lowering therapy beyond statins.

Session date: 
10/22/2026 - 12:00pm to 1:00pm EDT
Location: 
AGH Mackie-Sutton Room (2nd Floor South Tower) + Zoom Webinar
To Join the Zoom Webinar:
https://highmarkhealth.zoom.us/j/98672570454?pwd=VU80YWJYNjgraGVsQ0xkU2xSNWozQT09
Meeting ID: 986 7257 0454; Passcode: 877628
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Contact Hours
Please login or register to take this course.